![Michael Palfreyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Palfreyman
Director/Board Member at
THALIA THERAPEUTICS PLC
Net worth: - $ as of 30/05/2026
Profile
Michael Gavin Palfreyman was the founder of Amorsa Therapeutics, Inc. (2013) and served as Chief Scientific Officer.
Dr. Palfreyman is also the founder of Scriptgen Pharmaceuticals, Inc. Dr. Palfreyman is currently a Director at Amakem NV since 2011 and Vice President-Development at Brenig Therapeutics, Inc. Former positions include Chief Operating Officer & Director at Adelia Therapeutics, Inc., Chief Scientific Officer at Marc Pharmaceuticals, Inc., VP-Program Management & Product Development at FORUM Pharmaceuticals, Inc., Principal at Psychiatric Genomics, Inc., Principal at Torrey Pines Investment, Inc., and Chief Research & Development Officer at Cybin, Inc. Education includes a doctorate (1970), an undergraduate degree (1967), and a graduate degree (1971) from The University of Nottingham.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/12/2024 | 0 ( -.--% ) | - $ | 30/05/2026 |
Michael Palfreyman active positions
| Companies | Position | Start |
|---|---|---|
| THALIA THERAPEUTICS PLC | Director/Board Member | 08/09/2024 |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Director/Board Member | 24/08/2011 |
Brenig Therapeutics, Inc.
 Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Corporate Officer/Principal | - |
Former positions of Michael Palfreyman
| Companies | Position | End |
|---|---|---|
| CYBIN INC. | Chief Tech/Sci/R&D Officer | 04/06/2023 |
Amorsa Therapeutics, Inc.
 Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuron pharmaceutical company | Founder | 30/06/2019 |
Scriptgen Pharmaceuticals, Inc.
 Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Founder | - |
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company | Chief Operating Officer | - |
Torrey Pines Investment, Inc.
 Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Private Equity Investor | - |
Training of Michael Palfreyman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Scriptgen Pharmaceuticals, Inc.
Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Marc Pharmaceuticals, Inc.
 Marc Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage pharmaceutical company | Health Technology |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Psychiatric Genomics, Inc.
 Psychiatric Genomics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative small molecule drugs | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Finance |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuron pharmaceutical company | Health Technology |
Cybin, Inc.
 Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
- Stock Market
- Insiders
- Michael Palfreyman
